# Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

> **NCT07116213** · NA · RECRUITING · sponsor: **Xiaorong Hou** · enrollment: 20 (estimated)

## Conditions studied

- Endometrial Cancer
- Hypofractionated Dose
- Radiotherapy, Adjuvant
- Side Effects
- Survival , Tumor

## Interventions

- **RADIATION:** Moderately Hypofractionated Adaptive Radiotherapy

## Key facts

- **NCT ID:** NCT07116213
- **Lead sponsor:** Xiaorong Hou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2029-06-30
- **Final completion:** 2030-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116213, "Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT07116213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*